Journal Information
Visits
107
Review article
Full text access
Uncorrected Proof. Available online 29 September 2025
Myths and facts in the treatment of neurodevelopmental disorders – other therapies
Visits
107
Livio Francisco S. Chavesa,b,
, Fábio Borges Pessoab,c, Pedro Henrique Resende Marquesc,d
a Departamento de Desenvolvimento e Comportamento da Sociedade Brasileira de Pediatria, Rio de Janeiro, RJ, Brazil
b Fillium Centro Médico, Goiânia, GO, Brazil
c Departamento de Desenvolvimento e Comportamento da Sociedade Goiana de Pediatria, Goiânia, GO, Brasil
d Centro de Referência em Saúde |Mental (CRESM), Goiânia, GO, Brazil
This item has received
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Abstract
Objective

To critically examine the effectiveness of complementary and alternative therapies (CATs) in the treatment of neurodevelopmental disorders, distinguishing myths from evidence-based practices and supporting informed therapeutic decision-making for healthcare professionals, educators, and families.

Data sources

Evidence was collected from PubMed, Scopus, and Web of Science up to August 2025. Systematic reviews, meta-analyses, and international consensus statements addressing attention-deficit/hyperactivity disorder (ADHD), autism spectrum disorder (ASD), specific learning disorders, communication and language disorders, intellectual disability, and developmental coordination disorder were included.

Summary of findings

Interest in interventions such as neurofeedback, transcranial direct current stimulation, music therapy, equine-assisted therapy, virtual reality, and gamification has grown substantially. However, most of these approaches lack methodological standardization and robust evidence to justify their use as primary treatments. Some demonstrate modest benefits as adjunctive strategies, especially when integrated into structured programs and supervised by multidisciplinary teams. Conversely, therapies including acupuncture, ozone therapy, and hyperbaric oxygen therapy present insufficient scientific support and should not be considered substitutes for validated methods.

Conclusion

Complementary and alternative therapies remain a topic of significant debate in the management of neurodevelopmental disorders. While certain approaches may offer limited adjunctive benefits, their clinical use should be carefully evaluated within evidence-based frameworks. The development of rigorous evaluations, standardized protocols, and the safe integration of innovative technologies is essential to optimize therapeutic outcomes without compromising access to scientifically validated interventions.

Keywords:
Neurodevelopmental disorders
Complementary therapies
Myths and facts
Scientific evidence
Non-pharmacological interventions
Alternative therapies
Full Text
Introduction

Neurodevelopmental disorders comprise a heterogeneous group of early-onset conditions, typically manifesting before school age, characterized by deficits affecting cognitive, behavioral, motor, linguistic, and socioemotional functioning.1,2 The most prevalent conditions include attention-deficit/hyperactivity disorder (ADHD), autism spectrum disorder (ASD), specific learning disorders (SLD), communication and language disorders (CLD), intellectual disability (ID), and developmental coordination disorder (DCD).1,2

The etiology is multifactorial, resulting from the interaction between genetic predisposition, neurobiological alterations, and environmental factors, which together modulate the course and clinical expression of these disorders.1 Comorbidities are frequent and increase diagnostic and therapeutic complexity, requiring integrated and individualized approaches for optimal developmental outcomes.1,2

Although pharmacological and psychosocial interventions have established efficacy, interest in non-pharmacological therapies has been increasing, driven by expectations for “more natural” methods, limitations in response to conventional treatments, and the widespread circulation of information—often unvalidated—through digital media.1,3,4

CATs encompass structured behavioral interventions, digital technologies, motor training programs, non-invasive brain stimulation, and expressive therapies such as music therapy.3,5–7 Some have solid supporting evidence, while others lack standardization and replication, necessitating critical evaluation of efficacy and safety.3–5,8

The indiscriminate use of unproven methods may delay effective therapies, compromising critical windows of neuroplasticity and functional prognosis. The incorporation of new approaches should be guided by standardized protocols, multidisciplinary supervision, and outcome monitoring.3,5,8

This article critically reviews recent evidence on CATs for ADHD, ASD, specific learning disorders, communication and language disorders, intellectual disability, and DCD, based on 40 high-quality references (randomized controlled trials, systematic reviews, meta-analyses, and consensus statements), prioritizing those with the highest scientific impact and including essential classic studies.1–3,5

Attention-deficit/hyperactivity disorder

ADHD is a neurobiological disorder characterized by persistent symptoms of inattention, hyperactivity, and impulsivity, negatively impacting academic performance, interpersonal relationships, and emotional regulation.1–9 Neuroanatomical and neurofunctional alterations in frontostriatal circuits, as well as dopaminergic and noradrenergic dysfunctions, form the pathophysiological basis of the disorder.1–9 Non-pharmacological interventions play a relevant adjunctive role and, in specific cases, may serve as alternatives.3,5,9

Digital cognitive training (D-Cog) targeting working memory, selective attention, and inhibition promotes modest gains in neuropsychological measures, with variable transfer to clinical symptoms.5,3 D-Cog, as exemplified by EndeavorRx®, represents a technological innovation approved by regulatory agencies such as the FDA, aimed at improving specific executive functions.10 Although randomized controlled trials indicate discrete gains in sustained attention, the evidence does not yet support its standalone use due to inconsistent results and high cost, recommending its integration into multimodal programs.10

Neurofeedback, despite growing interest, is hampered by heterogeneous methodologies and a lack of standardization.11–15 Double-blind trials and meta-analyses suggest its effect may be equivalent to placebo when applied in isolation, reinforcing the need for its use as part of integrated multimodal programs.11,13–15

Mindfulness-based programs, such as MYmind, and online parental interventions demonstrate improvement in emotional regulation and reduction of family stress, achieving efficacy similar to group cognitive behavioral therapy.16,17 Aerobic physical activity is also associated with gains in inhibitory control and reductions in internalizing symptoms, although its recommendation as a standalone ADHD therapy remains insufficiently supported.16,17

Non-invasive brain stimulation, including transcranial direct current stimulation (tDCS) and transcranial magnetic stimulation (TMS), shows potential for modulating cortical excitability and promoting specific benefits in executive functions such as inhibition and processing speed.7,18,19 However, protocol variability and lack of long-term safety data limit its recommendation for routine clinical use.7,18,19

In summary, neurofeedback, mindfulness, and digital solutions have stronger empirical support as adjuncts, integrated into individualized, multimodal treatment plans.5,9–11,16–18

Specific learning disorders

Encompassing dyslexia, dyscalculia, and dysgraphia, these disorders are characterized by persistent, specific difficulties in acquiring and automating academic skills, unrelated to intellectual disability or isolated adverse environmental conditions.20 The neurobiological basis involves dysfunctions in the neural network responsible for phonological processing, attention, and visuospatial integration.20–22

The use of colored lenses and Irlen filters has been proposed to modulate visual perception and facilitate reading; however, robust evidence does not support their efficacy in improving reading fluency or comprehension.23 tDCS applied to brain areas associated with language has shown promising preliminary results in phonological modulation, although larger and more controlled studies are required for confirmation.20–22

Therapeutic digital games focused on phonological awareness, working memory, and auditory discrimination may enhance the effects of speech-language and psychopedagogical interventions, reinforcing the need for individualized, supervised approaches.20–22

Effective management of these disorders requires rigorous diagnosis, intensive and continuous interventions, and multidisciplinary follow-up to prevent associated academic delays and psychosocial impairments [20–23].

Autism spectrum disorder

ASD is defined by persistent deficits in social communication and restricted, repetitive behaviors, often accompanied by sensory alterations and cognitive rigidity.24,25 The etiology is complex, involving genetic and environmental factors resulting in dysfunctions across multiple brain networks, particularly in regions associated with sensory integration and socioemotional regulation.24,25 This complexity, coupled with sometimes slow or inconsistent therapeutic responses, has fueled the proliferation of alternative therapies, often marketed with promises of cure or complete rehabilitation.24,25

Among complementary therapies, music therapy and equine-assisted therapy have the strongest scientific support, promoting improvements in social engagement, communication, and motor organization—provided they are integrated into established behavioral training programs such as Applied Behavior Analysis (ABA).6,25,26

In contrast, practices such as acupuncture, ozone therapy, hyperbaric oxygen therapy, and osteopathy lack sufficient scientific evidence for clinical recommendation and may pose risks or delay established interventions.6,25,26

Non-invasive brain stimulation, such as tDCS and TMS, shows discrete effects in improving functional communication and emotional regulation; however, the absence of standardized protocols prevents routine use.27,28 Emerging technologies such as virtual reality offer potential for social skills training in adolescents with preserved intellectual functioning, though further studies are needed for broad validation.7,27,28

Despite CATs, ABA remains the gold standard in international guidelines for ASD intervention and should be prioritized in therapeutic plans.25

Communication and language disorders

CLDs range from expressive language delay to specific language impairment and social communication disorder. They are characterized by persistent deficits in language comprehension and/or expression, negatively affecting learning, socialization, and socioemotional development.1,20 Etiology is multifactorial, including genetic factors, structural and functional neurological alterations, and environmental influences.19

Evidence-based speech-language therapy—structured, intensive, and tailored to the patient’s profile—is the treatment of choice.1,20 Complementary approaches, such as digital games targeting phonological and semantic skills, may enhance gains when supervised by specialists.23 tDCS applied to cortical areas related to language has shown preliminary positive results, but lacks standardized protocols for routine use.7

The use of unproven therapies, such as unvalidated auditory stimulation or alternative methods without a scientific basis, may delay effective interventions and compromise functional prognosis.14

Intellectual disability

Characterized by significant limitations in intellectual functioning and adaptive behavior, ID begins during the developmental period and results from multiple causes, including genetic factors, perinatal insults, and environmental influences.1 There are no treatments capable of reversing ID, except in rare situations with treatable etiologies.1,29

The most effective interventions include early stimulation programs focusing on cognitive, social, and adaptive skills.1,30–32 ABA has robust evidence for improving adaptive skills and reducing challenging behaviors in individuals with ID, especially when started early and applied intensively.1,33

Assistive technologies, curricular adaptations, and accessibility resources promote school and social inclusion [1]. Virtual reality and gamification-based interventions have shown limited benefits for visuomotor coordination and motivation but still require validation in large-scale RCTs.33–38

Myths about “curing” ID persist and are often exploited by unproven approaches that divert resources and delay effective therapies.14

Developmental coordination disorder

DCD involves significant difficulties in acquiring and executing coordinated motor skills, affecting activities of daily living and school performance.1,29 Etiology includes dysfunctions in corticospinal and subcortical circuits responsible for motor planning.1,29

Task-oriented training programs, such as Neuromotor Task Training (NTT) and Task-Oriented Motor Training (TOMT), have the strongest evidence of efficacy, especially when integrated with structured physiotherapy and occupational therapy.4,29,30

Active video games (exergames) may serve as motivational tools for motor training but should not replace proven methods, given methodological heterogeneity and lack of standardization.29

Functional electrical stimulation and virtual reality also show specific benefits in coordination and reaction time, but still lack uniform protocols for widespread adoption.1,39,40

Discussion

Critical analysis of CATs in neurodevelopmental disorders reveals substantial methodological heterogeneity¹. Some interventions, such as neurofeedback, mindfulness, music therapy, and task-oriented motor training, have evidence supporting their use as adjuncts in specific contexts.1,33,34,39

In ADHD, approaches such as digital cognitive training and neurofeedback may provide additional gains when integrated with conventional treatments but do not replace pharmacotherapy and evidence-based psychosocial interventions.32–38,40

In ASD, music therapy and equine-assisted therapy demonstrate benefits in social engagement and communication and are recommended as complements to programs such as ABA. Unproven approaches like acupuncture, ozone therapy, and hyperbaric oxygen therapy should not be recommended.7,24–28

In SLDs and CLDs, digital technologies and tDCS have potential as auxiliary resources, but their effectiveness depends on integration into validated methods and professional supervision.1,7,20–23

In ID and DCD, early structured interventions and task-oriented motor training remain the cornerstones, with emerging technologies considered only as complements until stronger evidence becomes available.4,25,27,29,30,39

Conclusion

The use of CATs in managing neurodevelopmental disorders should follow rigorous scientific criteria, prioritizing safety, efficacy, and integration with validated treatments. While some demonstrate relevant benefits as adjuncts, none should replace methods recognized by international guidelines.1,40

Inappropriate application of these therapies may delay effective interventions and compromise prognosis. Therapeutic decisions should be shared among the multidisciplinary team, family, and patient, considering clinical context, functional impact, and available resources.1,2,5,40

Public policies and clinical guidelines should direct the careful incorporation of CATs, ensuring equitable access to evidence-based treatments while safely and responsibly exploring the potential of new technologies.1,2,5,40

Conflicts of interest

The authors declare no conflicts of interest.

References
[1]
A. Thapar, M. Cooper, M. Rutter.
Neurodevelopmental disorders.
Lancet Psychiatry, 4 (2017), pp. 339-346
[2]
R. Blank, B. Smits-Engelsman, H. Polatajko, P. Wilson, European Academy for Childhood Disability.
European Academy for Childhood Disability (EACD): recommendations on the definition, diagnosis and intervention of developmental coordination disorder (long version).
Dev Med Child Neurol, 54 (2012), pp. 54-93
[3]
M.H. Sibley, A.M. Bruton, X. Zhao, J.M. Johnstone, J. Mitchell, I. Hatsu, et al.
Non-pharmacological interventions for attention-deficit hyperactivity disorder in children and adolescents.
Lancet Child Adolesc Health, 7 (2023), pp. 415-428
[4]
K. Tapp, L. Vereenooghe, O. Hewitt, E. Scripps, K.M. Gray, P.E. Langdon.
Psychological therapies for people with intellectual disabilities: an updated systematic review and meta-analysis.
Compr Psychiatry, 122 (2023),
[5]
American Psychiatric Association.
Diagnostic and statistical manual of mental disorders.
5th ed., American Psychiatric Association, (2013), http://dx.doi.org/10.1176/appi.books.9780890425596
[6]
H. Mayer-Benarous, X. Benarous, F. Vonthron, D. Cohen.
Music therapy for children with autism spectrum disorder and/or other neurodevelopmental disorders: a systematic review.
Front Psychiatry, 12 (2021),
[7]
B.T. Gillick, W.E. Gordon, T. Feyma, L.E. Krach, J. Carmel, T.L. Rich, et al.
Non-invasive brain stimulation in children with unilateral cerebral palsy: a protocol and risk mitigation guide.
Front Pediatr, 6 (2018), pp. 56
[8]
T. Lun, S. Lin, Y. Chen, Y. Zhao, D. Wang, L. Li, et al.
Acupuncture for children with autism spectrum disorder: a systematic review and meta-analysis.
Medicine, 102 (2023),
[9]
J. Posner, G.V. Polanczyk, E. Sonuga-Barke.
Attention-deficit hyperactivity disorder.
Lancet. Lancet., 395 (2020), pp. 450-462
[10]
S.H. Kollins, D.J. DeLoss, E. Cañadas, J. Lutz, R.L. Findling, R.S. Keefe, et al.
A novel digital intervention for actively reducing severity of paediatric ADHD (STARS-ADHD): a randomised controlled trial.
Lancet Digit Health, 2 (2020), pp. e168-e178
[11]
S. Cortese, M. Ferrin, D. Brandeis, M. Holtmann, P. Aggensteiner, D. Daley, et al.
Cognitive training for attention-deficit/hyperactivity disorder: meta-analysis of clinical and neuropsychological outcomes.
J Am Acad Child Adolesc Psychiatry. J Am Acad Child Adolesc Psychiatry., 54 (2015), pp. 164-174
[12]
Neurofeedback Collaborative Group.
Double-blind placebo-controlled randomized clinical trial of neurofeedback for attention-deficit/hyperactivity disorder with 13-month follow-up.
J Am Acad Child Adolesc Psychiatry, 60 (2021), pp. 841-855
[13]
Neurofeedback Collaborative Group.
Neurofeedback for attention-deficit/hyperactivity disorder: 25-month follow-up of double-blind randomized controlled trial.
J Am Acad Child Adolesc Psychiatry, 62 (2023), pp. 435-446
[14]
F.L. Lin, C.K. Sun, Y.S. Cheng, M.Y. Wang, W. Chung, R.F. Tzang, et al.
Additive effects of EEG neurofeedback on medications for attention-deficit/hyperactivity disorder: a systematic review and meta-analysis.
Sci Rep, 12 (2022),
[15]
M. Van Dongen-Boomsma, M.A. Vollebregt, D. Slaats-Willemse, J.K. Buitelaar.
A randomized placebo-controlled trial of electroencephalographic (EEG) neurofeedback in children with attention-deficit/hyperactivity disorder.
J Clin Psychiatry, 74 (2013), pp. 821-827
[16]
S.Y. Wong, S.K. Chan, B.H. Yip, W. Wang, H.H. Lo, D. Zhang, et al.
The effects of mindfulness for youth (MYmind) versus group cognitive behavioral therapy in improving attention and reducing behavioral problems among children with ADHD and their parents: a randomized controlled trial.
Psychother Psychosom, 92 (2023), pp. 379-390
[17]
Z.J. Zhang, H.H. Lo, S.M. Bögels, R.Y. Cheung, E.N. Lau, E.K. Lee, et al.
A randomized controlled trial for evaluating the effects of an online mindfulness-based intervention for parents of children with attention-deficit/hyperactivity disorder: a study protocol.
BMC Psychol, 13 (2025), pp. 610
[18]
M.A. Salehinejad, E. Ghanavati, B. Glinski, A.H. Hallajian, A. Azarkolah.
A systematic review of randomized controlled trials on efficacy and safety of transcranial direct current stimulation in major neurodevelopmental disorders: ADHD, autism, and dyslexia.
Brain Behav, 12 (2022), pp. e2724
[19]
Sally J. Rogers, Laurie Vismara.
Interventions for infants and toddlers at risk for autism spectrum disorder.
[20]
R.L. Peterson, B.F. Pennington.
Developmental dyslexia.
Annu Rev Clin Psychol, 11 (2015), pp. 283-307
[21]
M.J. Snowling, C. Hulme.
Annual research review: the nature and classification of reading disorders—A commentary on proposals for DSM-5.
J Child Psychol Psychiatry, 53 (2012), pp. 593-607
[22]
T. Horowitz-Kraus, Z. Breznitz.
Can reading rate acceleration improve error monitoring and cognitive abilities underlying reading in adolescents with reading difficulties and in typical readers?.
[23]
P.G. Griffiths, R.H. Taylor, L.M. Henderson, B.T. Barrett.
The effect of coloured overlays and lenses on reading: a systematic review of the literature.
Ophthalmic Physiol Opt, 36 (2016), pp. 519-544
[24]
C. Lord, M. Elsabbagh, G. Baird, J. Veenstra-VanderWeele.
Autism spectrum disorder.
[25]
R.L. Gabriels, Z. Pan, B. Dechant, J.A. Agnew, N. Brim, G. Mesibov.
Randomized controlled trial of therapeutic horseback riding in children and adolescents with autism spectrum disorder.
J Am Acad Child Adolesc Psychiatry, 54 (2015), pp. 541-549
[26]
M. Geretsegger, C. Elefant, K.A. Mössler, C. Gold.
Music therapy for people with autism spectrum disorder.
Cochrane Database Syst Rev, 2014 (2014),
[27]
Y. Altın, Ö. Boşnak, C. Turhan.
Examining virtual reality interventions for social skills in children with autism spectrum disorder: a systematic review.
[28]
L.M. Oberman, P.G. Enticott, M.F. Casanova, A. Rotenberg, A. Pascual-Leone, J.T. McCracken, et al.
TMS in ASD Consensus Group. Transcranial magnetic stimulation in autism spectrum disorder: challenges, promise, and roadmap for future research.
Autism Res, 9 (2016), pp. 184-203
[29]
P. Wilson, S. Ruddock, S. Rahimi-Golkhandan, J. Piek, D. Sugden, D. Green, et al.
Cognitive and motor function in developmental coordination disorder.
Dev Med Child Neurol, 62 (2020), pp. 1317-1323
[30]
B. Smits-Engelsman, S. Vinçon, R. Blank, V.H. Quadrado, H. Polatajko, P.H. Wilson.
Evaluating the evidence for motor-based interventions in developmental coordination disorder: a systematic review and meta-analysis.
Res Dev Disabil, 74 (2018), pp. 72-102
[31]
J.C. Benedetti-Isaac, L. Camargo, M. Torres Zambrano, E. Perea-Castro, E. Castillo-Tamara, N. Caldichoury, et al.
Deep brain stimulation may be a viable option for resistant to treatment aggression in children with intellectual disability.
CNS Neurosci Ther, 29 (2023), pp. 2010
[32]
S. Enriquez-Geppert, R.J. Huster, C.S. Herrmann.
EEG-neurofeedback as a tool to modulate cognition and behavior: a review tutorial.
Front Hum Neurosci, 11 (2017), pp. 51
[33]
S.L. Hyman, S.E. Levy, S.M. Myers.
Council on children with disabilities, section on developmental and behavioral pediatrics. identification, evaluation, and management of children with autism spectrum disorder.
Pediatrics., 145 (2020),
[34]
S.V. Faraone, T. Banaschewski, D. Coghill, Y. Zheng, J. Biederman, M.A. Bellgrove, et al.
The world federation of ADHD international consensus statement: 208 evidence-based conclusions about the disorder.
Neurosci Biobehav Rev, 128 (2021), pp. 789-818
[35]
S. Enriquez-Geppert, R.J. Huster, C.S. Herrmann.
EEG-neurofeedback as a tool to modulate cognition and behavior: a review tutorial.
Front Hum Neurosci, 11 (2017), pp. 51
[36]
N. Beiman, R. Eitan, D. Todder, E. Keha, E. Kalanthroff.
The effect of transcranial direct current stimulation (TDCS) on cognitive functioning in individuals with attention deficit/hyperactivity disorder (ADHD).
Clin Neuropsychiatry, 22 (2025), pp. 87-98
[37]
H.R. Searight, K. Robertson, T. Smith, S. Perkins, B.K. Searight.
Complementary and alternative therapies for pediatric attention deficit hyperactivity disorder: a descriptive review.
ISRN Psychiatry, 2012 (2012),
[38]
M. Shrestha, J. Lautenschleger, N. Soares.
Non-pharmacologic management of attention-deficit/hyperactivity disorder in children and adolescents: a review.
Transl Pediatr, 9 (2020), pp. S114-S124
[39]
B.C. Smits-Engelsman, R. Blank, A.C. van der Kaay, R. Mosterd-van der Meijs, E. Vlugt-van den Brand, H.J. Polatajko, et al.
Efficacy of interventions to improve motor performance in children with developmental coordination disorder: a combined systematic review and meta-analysis.
Dev Med Child Neurol, 55 (2013), pp. 229-237
[40]
X. Yang, L. Zhang, J. Yu, M. Wang.
Short-term and long-term effect of non-pharmacotherapy for adults with ADHD: a systematic review and network meta-analysis.
Front Psychiatry, 16 (2025),
Download PDF
Idiomas
Jornal de Pediatria (English Edition)
Article options
Tools
en pt
Taxa de publicaçao Publication fee
A partir de 10 de fevereiro de 2025, haverá mudança no preço da taxa de publicação de todos os artigos que forem aceitos para publicação no Jornal de Pediatria. Ao submeterem o manuscrito a esta revista, os autores concordam com esses termos. A submissão dos manuscritos continua gratuita. Effective February 10, 2025, there will be changes in the Article Publishing Charge (APC) for all articles after peer review and acceptance in Jornal de Pediatria. By submitting the manuscript to this journal, the authors agree to these terms. Manuscript submission remains free of charge.
Cookies policy Política de cookies
To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here. Utilizamos cookies próprios e de terceiros para melhorar nossos serviços e mostrar publicidade relacionada às suas preferências, analisando seus hábitos de navegação. Se continuar a navegar, consideramos que aceita o seu uso. Você pode alterar a configuração ou obter mais informações aqui.